Aslan Pharmaceuticals Analysis
| ASLNDelisted Stock | USD 0.60 0.03 4.76% |
Aslan Pharmaceuticals is overvalued with Real Value of 0.57 and Hype Value of 0.6. The main objective of Aslan Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Aslan Pharmaceuticals is worth, separate from its market price. There are two main types of Aslan Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Aslan Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Aslan Pharmaceuticals is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Aslan Stock trading window is adjusted to America/New York timezone.
Aslan |
Aslan Stock Analysis Notes
About 13.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 16.0. Aslan Pharmaceuticals had not issued any dividends in recent years. The entity had 1:8 split on the 3rd of July 2024. ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company was founded in 2010 and is headquartered in Singapore. Aslan Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. For more info on Aslan Pharmaceuticals please contact Carl EMBA at 65 6817 9598 or go to https://aslanpharma.com.Aslan Pharmaceuticals Investment Alerts
| Aslan Pharmaceuticals is not yet fully synchronised with the market data | |
| Aslan Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aslan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12 M. Net Loss for the year was (44.22 M) with profit before overhead, payroll, taxes, and interest of 79.82 M. | |
| Aslan Pharmaceuticals currently holds about 78.12 M in cash with (46.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Aslan Pharmaceuticals Upcoming and Recent Events
Earnings reports are used by Aslan Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 22nd of March 2024 Upcoming Quarterly Report | View | |
| 26th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Aslan Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.7 M.Aslan Profitablity
The company has Profit Margin (PM) of (2.92) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.91) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.91.Aslan Pharmaceuticals Outstanding Bonds
Aslan Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aslan Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aslan bonds can be classified according to their maturity, which is the date when Aslan Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Aslan Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Aslan Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aslan shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Aslan Pharmaceuticals. By using and applying Aslan Stock analysis, traders can create a robust methodology for identifying Aslan entry and exit points for their positions.
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company was founded in 2010 and is headquartered in Singapore. Aslan Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Aslan Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |